Aims: The aim of this study was to assess patient perspectives and experiences of the impact of neuropathic pain, painful diabetic neuropathy (pDPN) diagnosis and treatment, and the patient-healthcare professional (HCP) relationship.Methods: We conducted a quantitative online survey in Germany, the Netherlands, Spain, and the UK among adults with diabetes who responded "yes" to at least four of ten questions of in the Douleur Neuropathique en 4 Questions (DN4) questionnaire.Results: Of 3626 respondents, 576 met the eligibility criteria. Daily pain was rated as moderate or severe by 79 % of respondents. Most participants reported a negative impact of their pain on sleep (74 %), mood (71 %), exercise (69 %), concentration (64 %) and daily activities (62 %), and 75 % of those in employment had missed work because of their pain in the past year. Overall, 22 % of respondents avoided discussing pain with their HCP, 50 % had not received formal pDPN diagnosis, and 56 % had not used prescribed pain medications. Although two-thirds (67 %) of respondents reported feeling satisfied or very satisfied with treatment, 82 % of these patients still experienced daily moderate or severe pain.Conclusions: Neuropathic pain in people with diabetes affects daily life and remains underdiagnosed and undertreated in clinical practice.

Diagnosis, management and impact of painful diabetic peripheral neuropathy: A patient survey in four European countries / Tesfaye, Solomon; Brill, Silviu; Eerdekens, Mariëlle; Labrador, Mercedes Maderuelo; Petersen, Gudula; de Rooij Peek, Angela; Reta, Ainhoa; Ryan, Deirdre; Schaper, Nicolaas; Tölle, Thomas; Truini, Andrea; Ziegler, Dan. - In: JOURNAL OF DIABETES AND ITS COMPLICATIONS. - ISSN 1056-8727. - 37:4(2023), p. 108417. [10.1016/j.jdiacomp.2023.108417]

Diagnosis, management and impact of painful diabetic peripheral neuropathy: A patient survey in four European countries

Truini, Andrea;
2023

Abstract

Aims: The aim of this study was to assess patient perspectives and experiences of the impact of neuropathic pain, painful diabetic neuropathy (pDPN) diagnosis and treatment, and the patient-healthcare professional (HCP) relationship.Methods: We conducted a quantitative online survey in Germany, the Netherlands, Spain, and the UK among adults with diabetes who responded "yes" to at least four of ten questions of in the Douleur Neuropathique en 4 Questions (DN4) questionnaire.Results: Of 3626 respondents, 576 met the eligibility criteria. Daily pain was rated as moderate or severe by 79 % of respondents. Most participants reported a negative impact of their pain on sleep (74 %), mood (71 %), exercise (69 %), concentration (64 %) and daily activities (62 %), and 75 % of those in employment had missed work because of their pain in the past year. Overall, 22 % of respondents avoided discussing pain with their HCP, 50 % had not received formal pDPN diagnosis, and 56 % had not used prescribed pain medications. Although two-thirds (67 %) of respondents reported feeling satisfied or very satisfied with treatment, 82 % of these patients still experienced daily moderate or severe pain.Conclusions: Neuropathic pain in people with diabetes affects daily life and remains underdiagnosed and undertreated in clinical practice.
2023
Diabetes complications; Diabetic neuropathies; Pain; Painful diabetic peripheral neuropathy; Surveys and questionnaires
01 Pubblicazione su rivista::01a Articolo in rivista
Diagnosis, management and impact of painful diabetic peripheral neuropathy: A patient survey in four European countries / Tesfaye, Solomon; Brill, Silviu; Eerdekens, Mariëlle; Labrador, Mercedes Maderuelo; Petersen, Gudula; de Rooij Peek, Angela; Reta, Ainhoa; Ryan, Deirdre; Schaper, Nicolaas; Tölle, Thomas; Truini, Andrea; Ziegler, Dan. - In: JOURNAL OF DIABETES AND ITS COMPLICATIONS. - ISSN 1056-8727. - 37:4(2023), p. 108417. [10.1016/j.jdiacomp.2023.108417]
File allegati a questo prodotto
File Dimensione Formato  
1-s2.0-S1056872723000156-main.pdf

solo gestori archivio

Note: Tesfaye_Diagnosis, management and impact_2023
Tipologia: Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza: Creative commons
Dimensione 1.31 MB
Formato Adobe PDF
1.31 MB Adobe PDF   Contatta l'autore

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/1684373
Citazioni
  • ???jsp.display-item.citation.pmc??? 0
  • Scopus 8
  • ???jsp.display-item.citation.isi??? 7
social impact